Of them, CDKN3 have been demonstrated to promote the malignant progression of cervical cancer,42 regulate cisplatin resistance to colorectal cancer43 and promote cell proliferation and invasion in human ovarian cancer.44 Here, CDKN3 is linked to ovarian cancer.